Home Amines 1243308-37-3
1243308-37-3,MFCD28502492
Catalog No.:AA000LSA

1243308-37-3 | Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5g
97%
in stock  
$7.00   $5.00
- +
10g
97%
in stock  
$13.00   $9.00
- +
100g
97%
in stock  
$106.00   $75.00
- +
500g
95%
in stock  
$474.00   $332.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA000LSA
Chemical Name:
Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride
CAS Number:
1243308-37-3
Molecular Formula:
C9H10Cl2N2O3
Molecular Weight:
265.0933
MDL Number:
MFCD28502492
SMILES:
CCOC(=O)C(=O)Nc1ccc(cn1)Cl.Cl
Properties
Computed Properties
 
Complexity:
248  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
4  

Downstream Synthesis Route

[1]CurrentPatentAssignee:BEIJINGSUNNOVOPHARMACEUTICALRES-CN108484641,2018,ALocationinpatent:Paragraph0048-0049;0081-0088

[2]CurrentPatentAssignee:LEPUMEDICALTECHNOLOGY(BEIJING)COMPANYLIMITED-CN105753888,2016,ALocationinpatent:Paragraph0012

[3]CurrentPatentAssignee:ZHEJIANGSUPORPHARMACEUTICALSCOLTD-CN111763169,2020,ALocationinpatent:Paragraph0023-0064

[4]CurrentPatentAssignee:MOEHSIBERICASL-WO2019/158550,2019,A1Locationinpatent:Page/Pagecolumn16-18

[5]CurrentPatentAssignee:HANSOHPHARMACEUTICALGROUPCOLTD-CN112940012,2021,ALocationinpatent:Paragraph0036-0037

[6]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1Locationinpatent:Page/Pagecolumn15-16

[7]CurrentPatentAssignee:INNERMONGOLIAJINGDONGPHARMACEUTICAL-CN111393456,2020,ALocationinpatent:Paragraph0077-0080

[8]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP1925611,2008,A1Locationinpatent:Page/Pagecolumn47

[9]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407450,2012,A1Locationinpatent:Page/Pagecolumn20-21

[10]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2589590,2013,A1Locationinpatent:Paragraph0141-0143

[11]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-US2015/353577,2015,A1Locationinpatent:Paragraph0095;0096

[12]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-JP5801011,2015,B2Locationinpatent:Page/Pagecolumn0206-0208

[13]CurrentPatentAssignee:SHENZHENKEXINGBIOTECH;SHANDONGKEXINGBIOPRODUCTS-CN104761571,2017,BLocationinpatent:Paragraph0043;0044;0045;0046;0047;0048

[14]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2021/1728,2021,A1Locationinpatent:Page/Pagecolumn12;20-22

[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407450,2012,A1Locationinpatent:Page/Pagecolumn20

[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1Locationinpatent:Page/Pagecolumn15

[3]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2589590,2013,A1Locationinpatent:Paragraph0139;0140

[4]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-US2016/16974,2016,A1

[5]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-JP5801011,2015,B2Locationinpatent:Page/Pagecolumn0203-0205

[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407450,2012,A1CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1

[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-JP5801011,2015,B2

[3]CurrentPatentAssignee:CHUNGWHACHEMICALSYNTHESISBIOTECH;CHINACHEMICALPHARMACEUTICALGROUP-TWI571460,2017,B

[4]CurrentPatentAssignee:SHENZHENKEXINGBIOTECH;SHANDONGKEXINGBIOPRODUCTS-CN104761571,2017,B

[5]CurrentPatentAssignee:BEIJINGSUNNOVOPHARMACEUTICALRES-CN108484641,2018,A

[6]CurrentPatentAssignee:INNERMONGOLIAJINGDONGPHARMACEUTICAL-CN111393456,2020,A

[7]CurrentPatentAssignee:INNERMONGOLIAJINGDONGPHARMACEUTICAL-CN111393456,2020,A

[8]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2021/1728,2021,A1

[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407450,2012,A1

[2]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1

[3]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1

[4]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2589590,2013,A1

[5]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-JP5801011,2015,B2

[6]CurrentPatentAssignee:CHUNGWHACHEMICALSYNTHESISBIOTECH;CHINACHEMICALPHARMACEUTICALGROUP-TWI571460,2017,B

[7]CurrentPatentAssignee:SHENZHENKEXINGBIOTECH;SHANDONGKEXINGBIOPRODUCTS-CN104761571,2017,B

[8]CurrentPatentAssignee:BEIJINGSUNNOVOPHARMACEUTICALRES-CN108484641,2018,A

[9]CurrentPatentAssignee:INNERMONGOLIAJINGDONGPHARMACEUTICAL-CN111393456,2020,A

[10]CurrentPatentAssignee:INNERMONGOLIAJINGDONGPHARMACEUTICAL-CN111393456,2020,A

[11]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2021/1728,2021,A1

[12]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2021/1728,2021,A1

[1]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP2407457,2012,A1Locationinpatent:Page/Pagecolumn19

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1243308-37-3 Molecular Formula|1243308-37-3 MDL|1243308-37-3 SMILES|1243308-37-3 Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hydrochloride